Elina Maharjan, NP
Nurse Practitioner · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 14 years
- Graduated 2012
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Elina Maharjan’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$13,488
Medicare paid this office $13,488 for 145 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 62 | $4,751 | $74 |
| New patient visit (30+ min) | 38 | $3,128 | $82 |
| Return visit (30+ min) | 16 | $1,566 | $98 |
| Short return visit | 15 | $753 | $47 |
| Automated urinalysis test | 21 | $46 | $2 |
Who their Medicare patients are
145 Original Medicare patients in 2024. Average age 75 · Women 66% · Also on Medicaid 17% · Health risk score 0.90. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 59% · Atrial fibrillation 21% · Depression 20% · Coronary heart disease 17% · Chronic kidney disease 17% · Cancer 17% · Diabetes 14% · Heart failure 9%.
The office billed $50,795, Medicare allowed $17,227 and paid $13,488; for 199 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 145 | 199 | 75 | 0.90 | $50,795 | $13,488 |
| 2020 | 89 | 121 | 70 | 0.79 | $5,664 | $3,969 |
| 2019 | 74 | 107 | 70 | 0.95 | $10,176 | $4,633 |
| 2018 | 97 | 167 | 70 | 0.86 | $13,994 | $5,714 |
| 2017 | 135 | 247 | 71 | 0.93 | $18,076 | $10,017 |
| 2016 | 152 | 287 | 72 | 1.06 | $18,285 | $11,282 |
| 2015 | 217 | 370 | 74 | 0.87 | $22,501 | $14,611 |
| 2014 | 152 | 516 | 71 | 1.65 | $122,437 | $39,468 |
| 2013 | 171 | 303 | 73 | 2.13 | $74,107 | $26,033 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2020: 3 services
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 60 | $1,462 | $24 |
| Influenza vaccine split virus, preservative free | 19 | $833 | $44 |
| Administration of influenza virus vaccine | 20 | $416 | $21 |
2019: 2 services
| New patient visit (30+ min) | 28 | $1,574 | $56 |
| Return visit (30+ min) | 26 | $1,322 | $49 |
2018: 3 services
| Return visit (30+ min) | 28 | $1,559 | $45 |
| New patient visit (30+ min) | 30 | $1,377 | $46 |
| New patient visit (15+ min) | 16 | $440 | $28 |
2017: 7 services
| New patient visit (30+ min) | 38 | $1,821 | $48 |
| Return visit (30+ min) | 28 | $1,634 | $56 |
| Influenza vaccine split virus, preservative free | 34 | $1,459 | $43 |
| Administration of influenza virus vaccine | 40 | $964 | $24 |
| New patient visit (15+ min) | 19 | $641 | $34 |
| Short return visit (20+ min) | 17 | $573 | $32 |
| Administration of pneumococcal vaccine | 14 | $332 | $24 |
2016: 9 services
| Pneumococcal vaccine, 13-valent | 17 | $2,978 | $175 |
| Influenza vaccine split virus, preservative free | 48 | $1,905 | $40 |
| New patient visit (30+ min) | 30 | $1,478 | $49 |
| Return visit (30+ min) | 22 | $1,055 | $46 |
| Administration of influenza virus vaccine | 50 | $1,029 | $21 |
| New patient visit (15+ min) | 26 | $896 | $34 |
| Short return visit (20+ min) | 21 | $872 | $40 |
| Administration of pneumococcal vaccine | 20 | $412 | $21 |
| Urinalysis, manual test | 16 | $55 | $3 |
2015: 9 services
| Pneumococcal vaccine, 13-valent | 24 | $4,073 | $170 |
| New patient visit (15+ min) | 66 | $2,363 | $36 |
| Influenza vaccine split virus, preservative free | 53 | $1,753 | $33 |
| New patient visit (30+ min) | 35 | $1,709 | $49 |
| Administration of influenza virus vaccine | 59 | $1,214 | $21 |
| Return visit (30+ min) | 17 | $890 | $49 |
| Short return visit (20+ min) | 21 | $829 | $39 |
| Administration of pneumococcal vaccine | 29 | $597 | $21 |
| Urinalysis, manual test | 14 | $44 | $3 |
2014: 5 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 68 | $19,167 | $113 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 51 | $7,288 | $65 |
| Short return visit (20+ min) | 56 | $3,976 | $44 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 28 | $3,833 | $72 |
| Return visit (30+ min) | 39 | $3,026 | $66 |
2013: 3 services
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 132 | $18,813 | $84 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 36 | $4,760 | $116 |
| Short return visit (20+ min) | 12 | $587 | $49 |
Medicaid work
$1,071 in 2020
Medicaid paid $1,071 for 179 billed services this clinician did in 2020, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 145 | $543 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 34 | $528 |
| 2020 | 179 | 2 | 63 | $1,071 |
Drugs they prescribed that Part D paid
$1,087
Pharmacies billed $1,087 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 97) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
87 generic and fewer than 11 brand-name prescriptions · $1,087 in drug cost · 50 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 23 | $168 | $7 |
Year by year
| 2024 | 97 | 82 | 0% (0) | None | $1,087 |
| 2019 | 67 | 57 | 0% (0) | 21% | $1,190 |
| 2018 | 78 | 65 | 0% (0) | 18% | $2,402 |
| 2017 | 103 | 80 | 0% (0) | 16% | $4,240 |
| 2016 | 111 | 83 | 0% (0) | 18% | $2,802 |
| 2015 | 205 | 128 | 0% (0) | None | $10,969 |
| 2014 | 766 | 83 | None | None | $89,348 |
| 2013 | 299 | 72 | None | None | $30,954 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 2 drugs
| Doxycycline Hyclate | 19 | $326 | $17 |
| Amoxicillin-Clavulanate Potass | 13 | $125 | $10 |
2016: 1 drug
| Amoxicillin-Clavulanate Potass | 22 | $264 | $12 |
2015: 2 drugs
| Proair Hfa | 12 | $615 | $51 |
| Amoxicillin-Clavulanate Potass | 33 | $305 | $9 |
2014: 23 drugs
| Nexium | 20 | $13,738 | $687 |
| Januvia | 17 | $12,646 | $744 |
| Advair Diskus | 14 | $4,670 | $334 |
| Proair Hfa | 11 | $785 | $71 |
| Levothyroxine | 37 | $742 | $20 |
| Montelukast | 21 | $739 | $35 |
| Atorvastatin | 36 | $713 | $20 |
| Pravastatin | 13 | $598 | $46 |
| Losartan | 18 | $458 | $25 |
| Potassium Chloride | 19 | $454 | $24 |
| Amlodipine Besylate-Benazepril | 12 | $404 | $34 |
| Clopidogrel | 13 | $300 | $23 |
| Fluticasone Propionate | 16 | $248 | $16 |
| Lisinopril | 31 | $245 | $8 |
| Amlodipine Besylate | 30 | $218 | $7 |
| Simvastatin | 12 | $204 | $17 |
| Gabapentin | 12 | $173 | $14 |
| Warfarin | 13 | $162 | $12 |
| Alendronate | 11 | $160 | $15 |
| Glimepiride | 11 | $157 | $14 |
| Furosemide | 26 | $130 | $5 |
| Metformin | 11 | $126 | $11 |
| Carvedilol | 15 | $121 | $8 |
2013: 3 drugs
| Atorvastatin | 11 | $481 | $44 |
| Amlodipine Besylate | 25 | $278 | $11 |
| Lisinopril | 11 | $140 | $13 |
Professional record
- NPI
- 1235470188
- Licence
- CA NP95013044, FL ARNP9395239, TX 749297
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-03-01
- NPI last updated
- 2024-10-03
- NPI record certified
- 2024-10-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2514 Berryessa Rd, San Jose, CA, 95132 · 2700 Homestead Rd, Santa Clara, CA, 95051 · 3501 54th Ave S, St Petersburg, FL, 33711